186 related articles for article (PubMed ID: 2366192)
1. Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline.
O'Donnell SR; Erjefält I; Persson CG
J Pharmacol Exp Ther; 1990 Jul; 254(1):65-70. PubMed ID: 2366192
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo.
Greiff L; Erjefält I; Erjefält JS; Wollmer P; Sundler F; Persson CG
Acta Physiol Scand; 1997 Aug; 160(4):387-91. PubMed ID: 9338520
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic control of plasma exudation into tracheobronchial airways.
Erjefält I; Persson CG
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1008-14. PubMed ID: 1902634
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
6. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs.
Sugimoto Y; Nakayama Y; Kishida H; Hayakawa T; Fujiwara R; Kamei C
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):547-52. PubMed ID: 9442478
[TBL] [Abstract][Full Text] [Related]
7. [Involvement of platelet activating factor (PAF) in ovalbumin antigen-induced late asthmatic response and increase of airway hyperresponsiveness in a guinea pig experimental model of asthma].
Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
Arerugi; 1991 Feb; 40(2):141-6. PubMed ID: 2069513
[TBL] [Abstract][Full Text] [Related]
8. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Pedersen KE; Rigby PJ; Goldie RG
Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
[TBL] [Abstract][Full Text] [Related]
11. Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.
Rogers DF; Dijk S; Barnes PJ
Br J Pharmacol; 1990 Nov; 101(3):739-45. PubMed ID: 2076490
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
13. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs].
Narita S; Asakura K; Shirasaki H; Kojima T; Saitoh H; Kataura A
Nihon Jibiinkoka Gakkai Kaiho; 1992 Aug; 95(8):1190-7. PubMed ID: 1357119
[TBL] [Abstract][Full Text] [Related]
14. Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide?
Rhee CK
Laryngoscope; 2003 Dec; 113(12):2059-66. PubMed ID: 14660903
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydrogen peroxide on the guinea-pig tracheobronchial mucosa in vivo.
Greiff L; Erjefält I; Erjefält JS; Wollmer P; Persson CG
Acta Physiol Scand; 1999 Apr; 165(4):415-20. PubMed ID: 10350237
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
[TBL] [Abstract][Full Text] [Related]
18. Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi.
O'Donnell SR; Barnett CJ
Eur J Pharmacol; 1987 Jun; 138(3):385-96. PubMed ID: 3040440
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.
Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T
Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
